HR-8430-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Deborah Ross (D-NC)
What it does
This bill would amend the Federal Food, Drug, and Cosmetic Act to explicitly authorize the FDA to share unredacted food safety information — including foodborne illness surveillance data, lab test results, inspection findings, recall distribution lists, and consumer complaints — with state, local, Tribal, and Territorial public health authorities. Recipient authorities would be prohibited from further disclosing that information without FDA permission, unless disclosure is necessary to contain an outbreak, carry out a recall, or support state enforcement. The bill would also extend the maximum duration of existing FDA food safety grants from 3 years to 5 years and make continued grant funding contingent on a successful program evaluation after the first year.
Who benefits
State, local, Tribal, and Territorial public health agencies, which would gain faster access to FDA data during foodborne illness outbreaks and recalls. The general public, which could benefit from faster outbreak containment and more coordinated recalls. Food safety inspectors and enforcement personnel at the sub-federal level, who would have more complete information to act on. Consumers in rural or Tribal areas where state agencies are often the primary enforcement presence. Food companies that comply with safety standards, who may benefit from faster identification and removal of non-compliant competitors. Grant recipients under the existing FDA food safety grant program, who would have access to longer funding cycles.
Who is hurt
Food manufacturers and distributors whose inspection records, consumer complaints, or lab results could be shared more broadly with sub-federal authorities, potentially increasing their exposure to state-level enforcement actions. Companies involved in recalls may face wider disclosure of distribution and complaint data than under current law. Grant applicants who do not pass the new first-year program evaluation would face earlier termination of funding. Existing grant recipients awarded before enactment are unaffected, but future applicants face a higher performance bar.
Supporters argue
Supporters argue that the current statutory framework — specifically the confidentiality provisions of Section 301(j) of the FD&C Act — creates a legal barrier that slows information sharing during active foodborne illness outbreaks, when speed is critical to preventing additional illness and death. They contend that state and local agencies are often the first responders to foodborne illness clusters but lack access to FDA surveillance data, lab results, and distribution lists that would allow them to act quickly. Supporters point to high-profile multistate outbreaks, such as those involving romaine lettuce and cantaloupe, where delayed information sharing between federal and state agencies was identified as a contributing factor to prolonged outbreak duration.
Opponents argue
Opponents argue that sharing unredacted inspection records, consumer complaints, and lab results with a broad range of sub-federal authorities — including local governments — creates significant risks of premature or inconsistent public disclosure that could harm food companies before findings are verified or enforcement actions are complete. They contend that the bill's limitation on further disclosure relies on recipient authorities' own judgment about when disclosure is "necessary," a standard that may be applied inconsistently across hundreds of jurisdictions. Critics may also argue that extending grant durations to five years without stronger accountability mechanisms could reduce the incentive for grantees to demonstrate measurable results in the early years of a program.